Why are more younger adults getting colorectal cancer? a national study digs into the data
NCT ID NCT07763314
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study examines national data from Switzerland to understand trends in early-onset colorectal cancer, which affects people under 50. By analyzing surgical cases from 2003 to 2022, researchers aim to see how common this cancer is, where it occurs, and what short-term outcomes look like after surgery. The findings could shed light on why rates are rising in younger adults and help improve care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This research could help identify patterns in early-onset colorectal cancer, potentially guiding earlier detection and better surgical care for younger patients.
- What could go wrong
- As a retrospective registry study, it can show associations but not prove causes. Data quality and completeness may vary, and findings may not apply beyond Switzerland.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
HOCH Health Ostschweiz, Kantonsspital St.Gallen
Sankt Gallen, St.Gallen, 9000, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo aims to boost response in Hard-to-Treat colorectal cancer
- First-in-Class cancer drug targets Hard-to-Treat tumors
- New pill targets Hard-to-Treat cancers with a specific gene mutation
- AI eye on cancer: robot helps spot hidden polyps
- New hope for Hard-to-Treat colorectal cancer? drug combo trial launches
- New drug cocktail aims to fight metastatic colorectal cancer